# Nutraceutical Potential of Astaxanthin in Muscle Metabolism, Exercise Adaptation, and Obesity

**Authors:** Juliana Silva Siqueira, Serena Castelli, Thiago Luiz Novaga Palacio, Gilda Aiello, Sara Baldelli, Alfonsina D’Amato, Alessandra De Bruno, Mauro Lombardo, Gianluca Tripodi

PMC · DOI: 10.3390/nu18010080 · Nutrients · 2025-12-26

## TL;DR

Astaxanthin may help improve muscle function, exercise recovery, and obesity-related issues by reducing inflammation and boosting metabolism.

## Contribution

This review highlights AX's potential in muscle metabolism, exercise adaptation, and obesity, emphasizing the need for better delivery methods.

## Key findings

- AX enhances lipid utilization and mitochondrial biogenesis via AMPK activation.
- AX reduces oxidative stress and muscle damage after exercise.
- AX improves insulin sensitivity and reduces adipose inflammation in obesity models.

## Abstract

Astaxanthin (AX), a naturally occurring xanthophyll carotenoid, has attracted growing scientific interest due to its potent antioxidant, anti-inflammatory, and metabolic-regulatory properties. This review provides a critical appraisal of the current evidence regarding the nutraceutical potential of AX in muscle metabolism, exercise adaptation, and obesity management. Preclinical and clinical findings indicate that AX enhances lipid utilization, promotes mitochondrial biogenesis through AMPK activation, and improves endurance and muscle strength, particularly among older adults. Moreover, AX mitigates exercise-induced oxidative stress and muscle damage, thereby supporting recovery and physiological adaptation. In obesity models, AX reduces adipose tissue inflammation, improves insulin sensitivity, and modulates adipokine secretion, suggesting a multifaceted role in metabolic syndrome prevention. Despite robust preclinical data, human trials remain limited and often yield inconsistent outcomes, highlighting the need for well-designed, long-term clinical studies. Emerging evidence highlights the importance of optimized delivery strategies to enhance AX bioavailability and mitochondrial targeting. Nanoemulsions, liposomes, and lipid-based carriers improve stability, absorption, and tissue distribution, thereby potentiating AX’s effects on mitochondrial function and exercise adaptation. Overall, AX emerges as a promising nutraceutical candidate for enhancing muscle function, supporting exercise performance, and managing obesity-related metabolic disease, with delivery innovations representing a critical frontier for future translational applications.

## Linked entities

- **Proteins:** PRKAA1 (protein kinase AMP-activated catalytic subunit alpha 1)
- **Chemicals:** Astaxanthin (PubChem CID 5281224)
- **Diseases:** obesity (MONDO:0011122), metabolic syndrome (MONDO:0000816)

## Full-text entities

- **Genes:** PRKAA2 (protein kinase AMP-activated catalytic subunit alpha 2) [NCBI Gene 5563] {aka AMPK, AMPK2, AMPKa2, PRKAA}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}
- **Diseases:** metabolic syndrome (MESH:D024821), muscle damage (MESH:D009133), metabolic disease (MESH:D008659), inflammation (MESH:D007249), Obesity (MESH:D009765)
- **Chemicals:** lipid (MESH:D008055), AX (MESH:C005948), xanthophyll (MESH:D024341), carotenoid (MESH:D002338)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12787713/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12787713/full.md

## References

135 references — full list in the complete paper: https://tomesphere.com/paper/PMC12787713/full.md

---
Source: https://tomesphere.com/paper/PMC12787713